Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2022 for La Jolla Pharmaceutical Co, €3,134.
Filing timeline
BuySaleLaura L. Johnson
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Laura L. Johnson: trading record in brief
Laura L. Johnson, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in La Jolla Pharmaceutical Co and TuHURA Biosciences, Inc./NV. In total, 2 filings cover trades dated from 22 November 2021 to 22 August 2022.
No open-market sale appears; the market trades are 1 purchase worth €1,975. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 24 August 2022: a transaction of €3,134, in La Jolla Pharmaceutical Co. The latest purchase dates back some time: it was published 1,795 days ago, on 24 November 2021. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Laura L. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
500 shares@ US$6.23100.0% of flowCommon StockSEC:0000899243-22-029651:0
3,000 shares@ US$0.7423100.0% of flowCommon StockSEC:0000899243-21-046043:0
Canonical exit: 20 Feb 2022 (T+90)
2 of 2 declarations
